China Reform Health Management and Services Group Co., Ltd is currently in a long term downtrend where the price is trading 15.3% below its 200 day moving average.

From a valuation standpoint, the stock is 382.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 46.5.

China Reform Health Management and Services Group Co., Ltd's total revenue rose by 30.2% to $29M since the same quarter in the previous year.

Its net income has dropped by 25.2% to $-42M since the same quarter in the previous year.

Finally, its free cash flow grew by 39.6% to $-25M since the same quarter in the previous year.

Based on the above factors, China Reform Health Management and Services Group Co., Ltd gets an overall score of 2/5.